Back to the complete issue
Monday, 2 January 2017

El Sisi gives nod to pharma price pacts, calls for more investment in the industry

El Sisi gives nod to pharma price pact, calls for more investment in industry: President Abdel Fattah El Sisi appeared to give a nod yesterday to an agreement between big pharma and the Health Ministry that would allow manufacturers hit by spiraling input costs to raise prices on a pre-determined schedule. A statement carried by state news agency MENA quotes El Sisi as having told cabinet “the government should ensure the availability of various types of medicines at affordable prices as well as provide imported drugs that have no domestic alternatives.” El Sisi also urged the government to “improve health care services, develop the local pharmaceutical industry and increase its competitiveness, and work to attract new investments,” Ahram Online reports.

Health Minister Ahmed Rady broke the government’s strategy for dealing with the issue into three phases: “in the short-term the ministry will increase prices and overcome shortages, in the medium-term by developing state-owned pharmaceutical factories, and in the long-term by expanding the pharmaceutical industry in Egypt.”

The Health Ministry has given domestic and international manufacturers two days to submit for approval their lists of products whose prices they want to hike, Al Mal reports. As we noted last month, pharma producers had reached an agreement with Rady to raise the prices of 15% of locally-produced meds and 20% of imported meds as of February. The agreement has allowed companies to resume imports of production inputs after a long pause that was instigated by higher costs following the EGP float. According to Al Borsa, both foreign and local players are already in the process of opening new LCs to cover their import needs.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of HSBC Egypt (tax ID: 204-901-715), the leading corporate and retail lender in Egypt; EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Mashreq (tax ID: 204-898-862), the MENA region’s leading homegrown personal and digital bank; Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt; Hassan Allam Properties (tax ID:  553-096-567), one of Egypt’s most prominent and leading builders; and Saleh, Barsoum & Abdel Aziz (tax ID: 220-002-827), the leading audit, tax and accounting firm in Egypt.